Monitor whether Celularity cures the Helena note default within the 5-day window. Failure to do so will trigger a significant debt acceleration and potential dilution from conversion. The NexGel deal provides cash but does not resolve the immediate default risk.
Price Chart
Executive Summary
Celularity announced the closing of its asset sale and licensing deal with NexGel, receiving $13.3 million in cash and a convertible note. Simultaneously, a convertible note held by Helena was triggered into default due to Celularity's late SEC filing, creating immediate financial pressure. Leadership changes were also announced as part of the strategic realignment.
Key Financial Metrics
Key Facts
- Closed $13.3 million transaction with NexGel for biomaterials assets: $8.3 million cash and a $5.0 million convertible note.
- Convertible note held by Helena was triggered into default due to Celularity's late 10-K filing, with a 5-day cure period.
- The default allows Helena to declare the 'Mandatory Default Amount' of 115% of the $1.97 million note, potentially accelerating repayment.
- Company announced leadership changes, including the termination of the Senior VP and resignation of the President of Degenerative Diseases.
Financial Impact
The $1.97 million note could balloon to $2.27 million (115%) if the default is not cured. The $13.3 million NexGel deal retires $13 million of debt.
Risk Factors
- The Helena note default could lead to immediate repayment of $2.27 million, creating a liquidity crisis.
- Failure to cure the default could result in a controlling equity stake being transferred to Helena upon conversion of the note.
- The leadership changes and asset sale signal a significant strategic retreat, raising concerns about the company's core business viability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-018220 |
| Exhibit: ex10-1.htm | 0001493152-26-018220 |
| Exhibit: ex99-1.htm | 0001493152-26-018220 |
| Document: form8-k.htm | 0001493152-26-018220 |
| Document: 0001493152-26-018220-index-headers.html | 0001493152-26-018220 |
| Document: 0001493152-26-018220-index.html | 0001493152-26-018220 |
| Document: 0001493152-26-018220.txt | 0001493152-26-018220 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 3, 2026 20w ago | 8-K | $0.008700 $0.008700 | · 0.00% | ▲ +1.37% | — |
May 28, 2026 21w ago | 8-K | $0.008700 $0.003300 | ▲ +62.07% | ▲ +60.27% | — |
Apr 21, 2026 27w ago | 8-K | $0.008700 $0.008700 | · 0.00% | ▲ +4.92% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers